Registry and prevalence of gene mutation in Korean patients with familial hypertrophic cardiomyopathy
- Conditions
- Diseases of the circulatory system
- Registration Number
- KCT0000777
- Lead Sponsor
- Korea Centers for Disease Control and Prevention
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 250
1. Patients diagnosed as hypertrophic cardiomyopathy
2. Family members of diagnosed patients
3. In cases of juvenile, above age-13(yrs)
Patients (male or female) who is diagnosed as hypertrophic cardiomyopathy following the guidlines, were to be asked and voluntarily participated with signing the consent to participate in research
- Guidelines
a. (Adults) Without the effect of hypertrophy-causing cardiac risks (fabry disease, danon disease, glycogen storage disease, etc.), maximal wall thickness (MWT) are increased more than 15mm in left ventricle with the echocardiography result.
b. (in juveniles(age-13 and above)) MWT are relatively increased as adults with regard to body surface area, and not dilated.
- Patients and family members who disagreed with the participation of research
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Types of Cardiomyopathy (CMP)
- Secondary Outcome Measures
Name Time Method Patient's pedigree infomation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.